MLX and osteosarcoma: Furthermore, ChIP-seq binding profiles of these two patients and three publicly available osteosarcoma patients [31] showed that MLX-associated super-enhancer sites were enriched in active histone modification marks such as H3K27ac (Fig. 1B and Supplementary Fig. S1a).